Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for Endometrial Thickness in IVF
NCT01202643Phase 2Terminated
- Sponsor
- Center for Human Reproduction
- Start
- Sep 2010
- Primary completion
- Feb 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of filgrastim in infertility (2 arms), sponsored by Center for Human Reproduction. Primary endpoint: Endometrial Thickness. Started Sep 2010; status: terminated.
02
Drugs
filgrastim
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01202643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202643.